Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 15.83 |  0.00 / 0.00% |
As of Sep 16 | Day’s Change |
| 15.52 |  -0.311 / -1.96% |
Volume: -- |
| Vical Slumps, Cytomegalovirus Vaccine Fails in Phase II Study Sep 20 / Zacks.com - Paid Partner Content | 2 Biotech Stocks that Turned $8,000 into over $250,000 Sep 12 / MotleyFool.com - Paid Partner Content |
| Previous close | 15.83 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 100 |
| Average volume (3 months) | 29,897 |
| Market cap | $34.1B |
| Dividend yield | 1.79% |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
